The much-maligned 1995 cyberpunk film envisioned a world of tech addiction, brain implants, and AI companions—ideas that feel eerily relevant in today's world.

Pharmaceutical air logistics is undergoing a structural transformation, as mergers, infrastructure investments, and real-time ...

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

Understanding these trends will equip life sciences leaders with the knowledge to convert volatility into sustainable ...

Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered ...

Viatris will likely encounter additional write-downs and impairments, along with macroeconomic headwinds. Click here to find out why VTRS stock is a Sell.

Velsera's Global Data Network Redefines How Pharma and Biotech Access Real-World, Longitudinal Clinicogenomic Data at ScaleThe federated network is powering faster, smarter drug development across ...

Sema4 Holdings Corp., now known as GeneDx Holdings Corp., must battle investor accusations that executives fraudulently painted a rosy picture of its artificial intelligence powered clinical and ...

Yet, an astonishing 97% of healthcare data goes unused, and over 70% of pharma research data searches end in failure. There's a clear need for a better way to seamlessly connect data with researchers.

Real-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design, support regulatory submissions, and demonstrate real-world value. From generating ...

Key Takeaways Real-world data enhances medication safety and supply chain efficiency. By collecting and applying data from manufacturing through administration, stakeholders can optimize inventory, ...